MedPath

Remote Magnetic Navigation-guided Ablation Versus Cryoablation for Persistent Atrial Fibrillation (RECREATION Study)

Not Applicable
Conditions
Persistent Atrial Fibrillation
Interventions
Procedure: Remote magnetic navigation
Procedure: Cryoablation
Registration Number
NCT03044925
Lead Sponsor
Ruijin Hospital
Brief Summary

Compare the safety and efficacy of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.

Detailed Description

1. Compare the efficacy of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.

2. Compare the safety of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.

3. Compare the procedural parameters of remote magnetic navigation-guided ablation and cryoablation for patients with persistent atrial fibrillation.

4. Compare the effects of amiodarone on recurrence after these two different ablation procedures.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
200
Inclusion Criteria
  1. Persistent atrial fibrillation (>7d, < 5years)
  2. Age 18-75 years
  3. Patient is mentally and linguistically able to understand the aim of the trial and to show sufficient compliance in following the trial protocol
Exclusion Criteria
  1. Any previous left atrial ablation or surgery
  2. Any cardiac surgery or percutaneous coronary intervention within 3 months prior to enrollment
  3. Stroke or transient ischemic attack within 6 months prior to enrollment
  4. Myocardial infarction within 3 months prior to enrollment
  5. Anteroposterior left atrial diameter > 55 mm

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Remote magnetic navigationRemote magnetic navigationPersistent atrial fibrillation ablation with remote magnetic navigation
CryoablationCryoablationPersistent atrial fibrillation ablation with cryoballoon
Primary Outcome Measures
NameTimeMethod
Clinical efficacy (time to first AF recurrence after blanking period)one year

the time to first AF recurrence after blanking period (month)

Clinical safety (Any procedure-related complications)one year

Any procedure-related complications

Secondary Outcome Measures
NameTimeMethod
QoL of 12 months (Units on a Scale)one year
Procedure time (min)one week
Time to first cardiovascular hospitalization (month)one year
X-ray time (min)one week
© Copyright 2025. All Rights Reserved by MedPath